Reuters logo
BRIEF-Novelion Therapeutics reports Qtrly loss per share $1.67
May 9, 2017 / 11:23 AM / 7 months ago

BRIEF-Novelion Therapeutics reports Qtrly loss per share $1.67

May 9 (Reuters) - Novelion Therapeutics Inc:

* Novelion Therapeutics reports first quarter 2017 financial results

* Sees FY 2017 revenue $155 million to $165 million

* Q1 revenue $30 million

* Qtrly loss per share $1.67

* Q1 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below